INTT inTest Corporation Q4 2025 EPS outperforms consensus estimates shares rise 674 percent on positive investor reaction ERO Ero Copper Q4 2025 EPS narrowly misses analyst estimates as shares log slight gains Bristol Myers Squibb BMY Valuation Deep Dive Assessing If The LargeCap Pharma Name Is The Best Bargain In Big Pharma